Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,501 to 1,520 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01CA137078 | Novel Biologically Targeted Therapy Against the Mer and Axl Receptor Tyrosine Kin | 18 | 2014 |
| U01CA143055 | Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression | 9 | 2014 |
| R01AI077519 | Filoviral glycoprotein/cellular protein interactions | 4 | 2014 |
| R01CA149260 | Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy | 4 | 2014 |
| R01GM094449 | Elucidation of Tubby and Tulp 1 Mechanisms by Comparitive Functional Proteomics | 4 | 2014 |
| R37CA068458 | IL-15 characterization through experimental immunology | 4 | 2014 |
| R01CA113669 | Developmental Signaling Pathways in Pancreatic Cancer | 3 | 2014 |
| K01ES017801 | Prenatal air pollution, DNA methylation and early signs of atherosclerosis | 2 | 2014 |
| K08CA154787 | Genetic Modifiers such as Fas Regulate Tumor-Cell Dependence on Mutant EGFR | 2 | 2014 |
| R00EY020865 | Molecular Mechanisms of Tubby and Tulp1 Mediated RPE Phagocytosis | 2 | 2014 |
| R01AI088027 | Mechanisms of Ebolavirus and Marburgvirus Entry into Cells | 2 | 2014 |
| R01CA134981 | KISS1: Defining Mechanisms for Antimetastatic Therapy | 2 | 2014 |
| R01CA151706 | Engineered HGF-NK1 antagonists for Met-targeted cancer imaging and therapy | 2 | 2014 |
| R01CA155521 | Elucidate and Modulate TGF-b Signaling in NK Cells for Glioma Treatment | 2 | 2014 |
| R37CA088480 | Hypoxia and Gene Repression | 2 | 2014 |
| R44CA168158 | Development of sEphB4-HSA as Novel Therapeutic in Cancer | 2 | 2014 |
| S10OD018522 | Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC Supercomputer | 2 | 2014 |
| DP2MH107055 | Studying epigenetic pathways in brain function and social behavior using ants | 1 | 2014 |
| F30CA165857 | Lgr5+ stem-like colon cancer cells contribute to chemoresistance | 1 | 2014 |
| F32AR065837 | Investigating the molecular mechanisms underlying lupus susceptibility conferred | 1 | 2014 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=76